Tanvex BioPharma Inc 6541
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 45.60
- Day Range
- TWD 45.70–46.60
- 52-Week Range
- TWD 44.00–88.95
- Bid/Ask
- TWD 45.85 / TWD 46.00
- Market Cap
- TWD 7.55 Bil
- Volume/Avg
- 89,000 / 344,222
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 96.52
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.tanvex.com
Comparables
Valuation
|
Metric
|
6541
|
6617
|
09966
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 7.50 | 15.59 | 2.62 |
Price/Sales | 96.52 | 1,089.72 | 18.83 |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
6541
|
6617
|
09966
|
|---|---|---|---|
Quick Ratio | 1.08 | 9.71 | 5.55 |
Current Ratio | 1.66 | 9.91 | 5.84 |
Interest Coverage | −36.74 | −21.66 | −22.37 |
Quick Ratio
6541
6617
09966
Profitability
|
Metric
|
6541
|
6617
|
09966
|
|---|---|---|---|
Return on Assets (Normalized) | −55.13% | −6.36% | −9.84% |
Return on Equity (Normalized) | −141.14% | −7.40% | −13.43% |
Return on Invested Capital (Normalized) | −57.48% | −9.25% | −13.97% |
Return on Assets
6541
6617
09966
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Mdbvzrrgp | Qgpq | $572.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Nvrtxgxp | Kqygq | $103.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Tfqslkts | Nfzjmn | $99.2 Bil | |
MRNA
| Moderna Inc | Vhqvrlhkv | Xfrl | $42.7 Bil | |
ARGX
| argenx SE ADR | Kzchpsjw | Jsjlq | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Zvvkgynv | Qnj | $21.7 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zlvzzmtw | Cfzqp | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Sgqdzrf | Swjrvx | $15.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Jfhlkphkg | Dbkrd | $12.7 Bil | |
INCY
| Incyte Corp | Rlhgtrf | Zntwx | $11.9 Bil |